Sg3 Management, LLC Cure Vac N.V. Call Options Transaction History

Sg3 Management, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 16, 2022	SELL	$14.73 - $35.25 $816,042 - $1.95 Million	-55,400 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$33.72 - $48.22 $1.87 Million - $2.67 Million	55,400 New	55,400 $1.9 Million
Q2 2021 Aug 16, 2021	SELL	$56.91 - $127.53 $6.83 Million - $15.3 Million	-120,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$46.76 - $136.27 $5.61 Million - $16.4 Million	120,000 New	120,000 $9.73 Million

12.3M

164K

117K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $514M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.